Table 5. Selectivity over inhibition of human mitochondrial protein synthesis and brain plasma ratio.
Compound number | Human mitochondrial protein synthesis EC50 (nM) | Selectivity index a | Brain/plasma ratio at 60 min (%) |
Compounds with 1,3-dihydro-imidazol-2-one linker | |||
15 | 42 b | 26 | 9.6 |
16 | 290 b | 85 | 0.1 |
17 | 430 b | 143 | 0 |
18 | 175 b | 30 | 0 |
20 | 195 b | 38 | 5.5 |
26 | 39 b | 39 | 0 |
27 | 75 b | 42 | 0 |
Compounds with fused ring linker | |||
39 | 507 | 145 | 0 |
40 | 478 | 154 | 0.5 |
42 | 1750 | 203 | 0.6 |
43 | 316 | 45 | 0 |
aSelectivity index is defined as EC50 against human mitochondrial protein synthesis divided by EC50 against T. brucei parasite growth.
bAs reported previously.19 Control for mitochondrial protein synthesis inhibition EC50 assay average ± SEM: chloramphenicol (7.9 ± 1.6 μM, n = 9).